biogen (biotechcompany)

literal strings:
  BIOGEN, Biogen, biogen
  Biogen Idec Inc.
  biogen_idec, BIOGEN IDEC, Biogen idec, Biogen Idec, Biogen IDEC, biogen idec, Biogen-Idec, Biogen-IDEC

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• biogen is a biotech company     
• biogen is a company     
• rituxan is a drug worked on by biogen (biotechcompany)     
• avonex is a drug worked on by biogen (biotechcompany)     
• james_mullen is a person who belongs to the organization biogen (biotechcompany)     
• james_mullen works for biogen (biotechcompany)     

categories

• biotechcompany(100.0%)
• CMC @1076 (100.0%) on 06-sep-2017 [ PREFIX=bio 5.05686 SUFFIX=gen 4.44889 SUFFIX=ogen 3.41212 SUFFIX=iogen 2.87889 PREFIX=bioge 2.72595 PREFIX=biog 2.61472 SHORT_WORDSHAPE=Aa 2.34087 SHORT_WORDSHAPE=a -2.85217 CHARS -3.08322 WORDS -3.87919 ] using biogen_idec
• Human feedback from estevam @888 on 02-dec-2014 [ "biogen generalizations company", Action=(+biotechcompany) (from NELL.08m.888.SSFeedback.csv) ] using biogen
• CPL @1098 (68.4%) on 21-jan-2018 [ "inventory acquired from _" "biotechnology companies , including _" "It is marketed by _" "_ now has exclusive rights" "biotechnology companies including _" "firm upgraded _" "_ 's Documentum" "_ announced FDA approval" "device companies including _" "grant/research support from _" "Class action lawsuit filed against _" "_ 's proprietary compounds" "corporate controller of _" "_ tells shareholders" "_ is a biotechnology company" "bioinformatics group at _" "_ immediately cease the dissemination" "major multinationals such as _" "drug being developed by _" "_ has won FDA approval" "_ 's clinical programs" "_ develops pharmaceuticals" "clinical development at _" "multinationals such as _" "unrestricted educational grant from _" "_ 's new drug" "_ has marketing rights" "drugmakers such as _" "current share price for _" "_ makes a drug" "vaccine developed by _" "_ 's Avonex" "biotech giant _" "speaker bureau for _" "medical device companies including _" "_ 's late-stage pipeline" "educational grant from _" "_ expects the FDA" "_ licensed rights" "_ is building a new plant" "grant support from _" "drug made by _" "pharmaceutical companies , including _" "_ 's drug discovery efforts" "study was sponsored by _" "drug developed by _" "drug produced by _" "cells were purchased from _" "PR rep from _" "pharmaceutical companies such as _" "various pharmaceutical companies , including _" "trial was supported by _" "live webcast , please visit _" "webcast , please visit _" "biotechnology companies such as _" "_ 's Tysabri" "_ recognized revenue" "Neutral rating on _" "drug discovery at _" "cancer treatment developed by _" "global marketing at _" ] using biogen
• CMC @1076 (100.0%) on 06-sep-2017 [ LASTPREFIX=bio 1.66314 PREFIX=bio 1.42448 LASTPREFIX=bi 1.31087 LASTSUFFIX=gen 1.20243 SUFFIX=gen 1.19393 SUFFIX=ogen 1.17963 LASTSUFFIX=ogen 1.16152 FULL_WORDSHAPE=Aa -0.69608 SHORT_WORDSHAPE=a -0.77554 FULL_POS=NN -2.00551 ] using biogen
• CPL @1103 (83.9%) on 08-mar-2018 [ "IP Counsel at _" "_ 's first-quarter profit" "biopharmaceutical companies , including _" "drug made by _" "medicine made by _" "company acquired by _" "drug developed by _" "antibody developed by _" "_ 's Rituxan" "drug marketed by _" "_ 's Avonex" "monoclonal antibody developed by _" "collaboration agreement with _" ] using biogen_idec_inc_
• OE @1063 (100.0%) on 04-jun-2017 [ http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://en.wikipedia.org/wiki/Biogen_Idec http://www.bloomberg.com/quote/BIIB:US http://www.biogenidechemophilia.com/ http://quotes.wsj.com/BIIB http://en.wikipedia.org/wiki/Biogen_Idec http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://en.wikipedia.org/wiki/Biogen_Idec http://www.biogenidec.nl/ http://www.avonex.com/ http://www.avonex.com/ http://www.avonex.com/ http://en.wikipedia.org/wiki/Biogen_Idec  ] using biogen
• OE @1057 (100.0%) on 13-may-2017 [ http://www.bloomberg.com/quote/BIIB:US http://www.google.com/finance?cid=657403 http://www.forbes.com/companies/biogen-idec/ http://www.wsj.com/articles/biogen-drops-idec-from-name-1427113639  ] using biogen_idec_inc_
• CPL @1097 (82.4%) on 19-jan-2018 [ "players covered are _" "market players covered are _" "Key market players covered are _" ] using biogen_idec
• SEAL @214 (99.9%) on 22-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 ] using biogen
• SEAL @214 (100.0%) on 22-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using biogen_idec
• CMC @1048 (99.9%) on 10-apr-2017 [ SUFFIX=gen 1.14264 PREFIX=bio 0.81628 PREFIX=in 0.71336 LAST_WORD=inc. 0.65250 LASTSUFFIX=nc. 0.65182 LASTPREFIX=in 0.60795 SUFFIX=iogen 0.58022 POS=NN -0.04188 WORDSHAPE=Aaaa -0.32385 WORDS -1.02906 ] using biogen_idec_inc_
• company(100.0%)
• Seed
• CPL @1097 (95.2%) on 19-jan-2018 [ "biotech companies including _" "speakers bureaus of _" "companies such as _" "companies like _" "major companies including _" "_ 's Avonex" ] using biogen_idec
• OE @901 (92.9%) on 13-feb-2015 [ http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://en.wikipedia.org/wiki/Biogen_Idec http://www.biogenidechemophilia.com/ http://www.avonex.com/ http://quotes.wsj.com/BIIB http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://en.wikipedia.org/wiki/Biogen_Idec http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://topics.nytimes.com/top/news/business/companies/biogen_idec_inc/index.html http://www.biogenidec.nl/ http://www.bloomberg.com/quote/BIIB:US http://en.wikipedia.org/wiki/Biogen_Idec http://www.biogenidec.com/careers.aspx?ID=11619 http://www.biogenidec.com/ http://www.biogenidec.nl/ https://www.biogenidec.com/events_and_webcasts.aspx?ID=6017 http://www.biogenidec.ch/  ] using biogen
• CMC @1076 (100.0%) on 06-sep-2017 [ PREFIX=bio 3.84480 SUFFIX=iogen 3.41331 SHORT_WORDSHAPE=Aa 3.19314 WORDSHAPE=AAAA 2.90662 PREFIX=bioge 2.88924 PREFIX=biog 2.72662 SUFFIX=ogen 2.41729 FULL_WORDSHAPE=a_a -1.60882 PREFIX=bi -2.72410 CHARS -3.69505 ] using biogen_idec
• OE @1015 (100.0%) on 09-sep-2016 [ http://www.google.com/finance?cid=657403 http://www.bloomberg.com/quote/BIIB:US http://www.forbes.com/companies/biogen-idec/ http://www.wsj.com/articles/biogen-drops-idec-from-name-1427113639  ] using biogen_idec_inc_
• CMC @1076 (100.0%) on 06-sep-2017 [ SUFFIX=iogen 1.39377 LASTSUFFIX=iogen 1.37287 PREFIX=bioge 1.33029 LASTSUFFIX=gen 1.32948 LASTPREFIX=bioge 1.20474 LASTPREFIX=biog 1.16947 LASTSUFFIX=ogen 1.16127 PREFIX=bi -0.62077 FULL_WORDSHAPE=Aa -0.78910 FULL_POS=NN -0.88789 ] using biogen
• CMC @1010 (99.2%) on 04-aug-2016 [ SHORT_WORDSHAPE=Aa 0.99366 LAST_WORD=inc. 0.56910 LASTSUFFIX=nc. 0.53800 SUFFIX=nc. 0.50408 PREFIX=bio 0.46778 LASTPREFIX=inc 0.45135 SUFFIX=iogen 0.44797 WORDS -0.26334 PREFIX=bi -0.34523 CHARS -0.76604 ] using biogen_idec_inc_
• SEAL @622 (100.0%) on 07-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ] using biogen_idec
• Seed
• SEAL @1 (75.0%) on 12-jan-2010 [ 1 2 ] using biogen

relations

• agentcollaborateswithagent
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~_X0~concept:controlledbyagent" "Y~X0~concept:superpartof" ] using (biogen_idec, james_mullen)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~_X0~concept:controlledbyagent" "Y~X0~concept:superpartof" ] using (james_mullen, biogen_idec)
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~_X0~concept:controlledbyagent" "Y~X0~concept:superpartof" ] using (biogen_idec, james_mullen)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~_X0~concept:controlledbyagent" "Y~X0~concept:superpartof" ] using (james_mullen, biogen_idec)
• agentcontrols
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcollaborateswithagent" "Y~_X0~concept:agentcollaborateswithagent" "Y~X0~concept:agentinteractswithagent" "Y~_X0~concept:agentinteractswithagent" "Y~_X0~concept:controlledbyagent" ] using (biogen_idec, james_mullen)
• agentworkedondrug
• rituxan (98.4%)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 by Genentech and arg2" ] using (rituxan, biogen_idec)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (rituxan, biogen_idec)
• avonex (93.8%)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (avonex, biogen)
• SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (avonex, biogen_idec)
• mutualproxyfor
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:mutualproxyfor,concept:agentcontrols" ] using (biogen_idec, james_mullen)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:mutualproxyfor,concept:agentcontrols" ] using (james_mullen, biogen_idec)
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:mutualproxyfor,concept:agentcontrols" ] using (biogen_idec, james_mullen)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:mutualproxyfor,concept:agentcontrols" ] using (james_mullen, biogen_idec)
• organizationhasagent
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:relatedto,concept:agenthierarchicallybelowagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentinteractswithagent" "Y~_X0~concept:proxyfor" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentcollaborateswithagent" ] using (james_mullen, biogen_idec)
• organizationhasperson
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:mutualproxyfor" "Y~_X0~concept:proxyfor" ] using (james_mullen, biogen_idec)
• organizationleadbyperson
• james_mullen (96.9%)
• SEAL @563 (96.9%) on 09-may-2012 [ 1 2 3 4 5 ] using (james_mullen, biogen_idec)
• worker
• james_mullen (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" "Y~X0~concept:agentleadsorganization" ] using (james_mullen, biogen_idec)